Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC
Akito Natsume, Rinpei Niwa, Mitsuo SatohAntibody Research Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltd.,/Machida-shi, Tokyo, JapanAbstract: As platforms for therapeutic agents, monoclonal antibodies (MAbs) have already been approved, and several MAbs have demonstrated clinical effecti...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-12-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/improving-effector-functions-of-antibodies-for-cancer-treatment-enhanc-a2721 |